Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome

European Journal of Cancer

Volumn 49, Issue 7, 2013, Pages 1673-1682

  Trédan, Olivier ^a   Manuel, Manuarii ^a,b,c,d,e   Clapisson, Gilles ^a   Bachelot, Thomas ^a,b,c,d   Chabaud, Sylvie ^a   Bardin Dit Courageot, Christine ^a   Rigal, Chantal ^a   Biota, Cathy ^a,b,c,d   Bajard, Agathe ^a   Pasqual, Nicolas ^e   Blay, Jean Yves ^a,b,c,d   Caux, Christophe ^a,b,c,d   Ménétrier Caux, Christine ^a,b,c,d  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^e CEA GRENOBLE   (France)

Author keywords

CD4 lymphopaenia; Metastatic breast cancer; Prognostic factors; Survival

Indexed keywords

CD19 ANTIGEN; CD56 ANTIGEN; MACROPHAGE DERIVED CHEMOKINE;

ADULT; ARTICLE; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; BREAST NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL22; COHORT STUDIES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOPENIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; TIME FACTORS;

EID: 84876149504     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.11.028     Document Type: Article

References (35)

1. G.P. Dunn, L.J. Old, and R.D. Schreiber The immunobiology of cancer immunosurveillance and immunoediting Immunity 21 2004 137 148 (Pubitemid 39094044)
2. M.J. Gooden, G.H. de Bock, N. Leffers, T. Daemen, and H.W. Nijman The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis Br J Cancer 105 2011 93 103
3. J. Galon, A. Costes, and F. Sanchez-Cabo Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 2006 1960 1964 (Pubitemid 44498003)
4. S.I. Labidi-Galy, V. Sisirak, and P. Meeus Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer Cancer Res 71 2011 5423 5434
5. C. Menetrier-Caux, G. Montmain, and M.C. Dieu Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor Blood 92 1998 4778 4791 (Pubitemid 29005881)
6. I. Treilleux, J.Y. Blay, and N. Bendriss-Vermare Dendritic cell infiltration and prognosis of early stage breast cancer Clin Cancer Res 10 2004 7466 7474 (Pubitemid 39561754)
7. J. Faget, C. Biota, and T. Bachelot Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells Cancer Res 71 2011 6143 6152
8. M. Gobert, I. Treilleux, and N. Bendriss-Vermare Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome Cancer Res 69 2009 2000 2009
9. M. Manuel, O. Tredan, and T. Bachelot Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients Oncoimmunology 1 2012 432 440
10. F.S. Hodi, S.J. O'Day, and D.F. McDermott Improved survival with ipilimumab in patients with metastatic melanoma N Engl J Med 363 2010 711 723
11. S.L. Topalian, F.S. Hodi, and J.R. Brahmer Safety, activity, and immune correlates of anti-PD-1 antibody in cancer N Engl J Med 366 2012 2443 2454
12. J. Chang, G.M. Clark, D.C. Allred, S. Mohsin, G. Chamness, and R.M. Elledge Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor Cancer 97 2003 545 553 (Pubitemid 36125831)
13. R. Largillier, J.M. Ferrero, and J. Doyen Prognostic factors in 1038 women with metastatic breast cancer Ann Oncol 19 2008 2012 2019
14. M. Ryberg, D. Nielsen, K. Osterlind, T. Skovsgaard, and P. Dombernowsky Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy Ann Oncol 12 2001 81 87 (Pubitemid 32162451)
15. O. Tredan, I. Ray-Coquard, and G. Chvetzoff Validation of prognostic scores for survival in cancer patients beyond first-line therapy BMC Cancer 11 2011 95 104
16. S. Dawood, K. Broglio, J. Ensor, G.N. Hortobagyi, and S.H. Giordano Survival differences among women with de novo stage IV and relapsed breast cancer Ann Oncol 21 2010 2169 2174
17. T. Bachelot, I. Ray-Coquard, and G. Catimel Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials Ann Oncol 11 2000 151 156 (Pubitemid 30148727)
18. T. Bachelot, I. Ray-Coquard, C. Menetrier-Caux, M. Rastkha, A. Duc, and J.Y. Blay Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients Br J Cancer 88 2003 1721 1726 (Pubitemid 36760416)
19. J.Y. Blay, F. Chauvin, and A. Le Cesne Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia J Clin Oncol 14 1996 636 643 (Pubitemid 26051031)
20. C. Borg, I. Ray-Coquard, and I. Philip CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer Cancer 101 2004 2675 2680 (Pubitemid 39532301)
21. N. Penel, J.P. Delord, and M.E. Bonneterre Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics Invest New Drugs 28 2010 76 82
22. I. Ray-Coquard, A. Le Cesne, and M.T. Rubio Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 study group J Clin Oncol 17 1999 2840 2846 (Pubitemid 29415242)
23. I. Ray-Coquard, H. Ghesquiere, and T. Bachelot Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas Br J Cancer 85 2001 816 822 (Pubitemid 33010546)
24. I. Ray-Coquard, C. Borg, and T. Bachelot Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy Br J Cancer 88 2003 181 186 (Pubitemid 36255833)
25. I. Ray-Coquard, C. Cropet, and M. Van Glabbeke Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas Cancer Res 69 2009 5383 5391
26. P. Seve, I. Ray-Coquard, and V. Trillet-Lenoir Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site Cancer 107 2006 2698 2705 (Pubitemid 44845626)
27. J. Peron, C. Cropet, and O. Tredan CD4 lymphopenia to identify end-of-life metastatic cancer patients Eur J Cancer 49 5 2013 1080 1089
28. J.Y. Blay, A. Le Cesne, and C. Mermet A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy Blood 92 1998 405 410 (Pubitemid 28323701)
29. V. Milasiene, E. Stratilatovas, and V. Norkiene The importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patients Medicina 43 2007 548 554
30. F. Ossendorp, R.E. Toes, R. Offringa, S.H. van der Burg, and C.J. Melief Importance of CD4(+) T helper cell responses in tumor immunity Immunol Lett 74 2000 75 79
31. S. Ferrando-Martinez, J.M. Franco, and A. Hernandez Thymopoiesis in elderly human is associated with systemic inflammatory status Age (Dordr) 31 2009 87 97
32. C.C. Bleul, and T. Boehm Chemokines define distinct microenvironments in the developing thymus Eur J Immunol 30 2000 3371 3379 (Pubitemid 32005207)
33. T. Hirota, H. Saeki, and K. Tomita Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studies PLoS One 6 2011 e26987
34. G. Wang, D. Yu, W. Tan, D. Zhao, C. Wu, and D. Lin Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma Cancer 115 2009 2430 2437
35. H.A. Whittington, R.W. Freeburn, S.I. Godinho, J. Egan, Y. Haider, and A.B. Millar Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis Genes Immun 4 2003 258 264 (Pubitemid 39562124)